A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

Clinical trial NCT05360680 · COMPLETED

Trial details

NCT number: NCT05360680
Sponsor: Cue Biopharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Gastric Cancer Pancreatic Cancer Ovarian Cancer

Start date: 2022-06-14
Primary completion: 2025-03-12
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.